Please use this identifier to cite or link to this item:
DC FieldValue
dc.titleIdentification of mature nocistatin and nociceptin in human brain and cerebrospinal fluid by mass spectrometry combined with affinity chromatography and HPLC
dc.contributor.authorJoseph, T.
dc.contributor.authorLee, T.L.
dc.contributor.authorTachibana, S.
dc.contributor.authorNing, C.
dc.contributor.authorNishiuchi, Y.
dc.contributor.authorKimura, T.
dc.contributor.authorJikuya, H.
dc.contributor.authorOu, K.
dc.contributor.authorChin, Y.C.
dc.identifier.citationJoseph, T., Lee, T.L., Tachibana, S., Ning, C., Nishiuchi, Y., Kimura, T., Jikuya, H., Ou, K., Chin, Y.C. (2006). Identification of mature nocistatin and nociceptin in human brain and cerebrospinal fluid by mass spectrometry combined with affinity chromatography and HPLC. Peptides 27 (1) : 122-130. ScholarBank@NUS Repository.
dc.description.abstractNocistatin (NST) and nociceptin/orphanin FQ (NCP) are two important bio-peptides derived from the precursor protein prepronociceptin (ppNCP), involved in several central nervous system (CNS) functions including pain transmission. Since the actual form of human NST in CNS is not fully characterized, we studied the structure of NST from human brain tissue and cerebrospinal fluid (CSF) samples. NST and NCP were isolated from human brain and CSF samples by affinity chromatography combined with HPLC. Mass spectrometry was used for the identification and characterization of the peptides. The total NST immunoreactivity was detected as 11.5 ± 2.3 pmol/g tissue for the brain and 0.44 pmol/ml for the pooled CSF sample after the HPLC purification by radioimmunoassay. The presence of two different forms of mature nocistatin (NST-17 and NST-30) and a possible N-terminal methionine cleaved NST-29 were confirmed by both radioimmunoassay and mass spectrometry. Affinity chromatography, HPLC and mass spectrometry methods used in this study were highly sensitive and suitable for identification of actual chemical structures and quantification of very small amounts of peptides in biological samples. The present findings may help further for search for new treatment of neuropathic pain, which is often poorly managed by current therapies. © 2005 Elsevier Inc. All rights reserved.
dc.subjectAffinity chromatography
dc.subjectCerebrospinal fluid
dc.subjectHuman brain
dc.subjectMALDI-TOF mass
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.